Ws. Jellish et al., Somatosensory evoked potential monitoring used to compare the effect of three asymmetric sternal retractors on brachial plexus function, ANESTH ANAL, 88(2), 1999, pp. 292-297
Citations number
18
Categorie Soggetti
Aneshtesia & Intensive Care","Medical Research Diagnosis & Treatment
We compared the effect of three different asymmetric sternal retractors on
brachial plexus dysfunction using intraoperative somatosensory evoked poten
tials (SSEPs). We studied 60 patients undergoing coronary bypass and intern
al mammary harvest. Assessment of brachial plexus function was performed pr
e- and postoperatively. Patients were assigned the use of a Pittman(TM) (MN
Scientific Instruments Inc., Minneapolis, MN), Rultract(TM) (Rultract Inc.
, Cleveland, OH),or Delacroix-Chevalier(TM) (Delacroix-Chevalier, Paris, Fr
ance) asymmetric sternal retractor for internal mammary exposure. SSEP chan
ges from baseline during asymmetric retractor use and removal were determin
ed, and average changes were compared among the retractor groups. Patient d
emographics and baseline SSEP values were similar. Fewer patients in the De
lacroix-Chevalier(TM) group had decreases in SSEP amplitudes after retracto
r placement. Of the patients in the Rultract(TM) and Pittman(TM) groups, 45
% and 25%, respectively, had amplitude decreases of >50%, compared with onl
y 5% of the Delacroix-Chevalier(TM) patients. Three patients in both the Pi
ttman(TM) and Rultract(TM) groups and one patient in the Delacroix-Chevalie
r(TM) group suffered brachial plexus symptoms postoperatively. We conclude
that the Delacroix-Chevalier(TM) retractor is associated with less neurophy
siologic evidence of brachial plexus dysfunction during asymmetric sternal
retraction compared with either the Pittman(TM) or Rultract(TM) sternal ret
ractors. Implications: We used somatosensory evoked potentials to assess th
e effect of several different asymmetric sternal retractors on brachial ple
xus dysfunction and to determine which produced the least evidence of nerve
damage during surgical exposure of the internal mammary artery.